Maccura BiotechnologyLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wu Mingjian
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Does Maccura BiotechnologyLtd (SZSE:300463) Have A Healthy Balance Sheet?
Dec 12
Even With A 38% Surge, Cautious Investors Are Not Rewarding Maccura Biotechnology Co.Ltd's (SZSE:300463) Performance Completely
Oct 08Is Maccura BiotechnologyLtd (SZSE:300463) Using Too Much Debt?
Aug 01Many Still Looking Away From Maccura Biotechnology Co.Ltd (SZSE:300463)
May 28Some Investors May Be Willing To Look Past Maccura BiotechnologyLtd's (SZSE:300463) Soft Earnings
May 01CEO
Wu Mingjian (47 yo)
9.3yrs
Tenure
CN¥1,314,000
Compensation
Mr. Wu Mingjian serves as General Manager of Maccura Biotechnology Co. Ltd and serves as its Director since August 14, 2015. He served as Commercial Director and Finance Manager at Maccura Biotechnology Co...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 9.3yrs | CN¥1.31m | 0.24% CN¥ 20.1m | |
| CFO & Director | 2.1yrs | CN¥843.60k | 0.043% CN¥ 3.6m | |
| Director of Marketing & Director | 7.3yrs | CN¥355.40k | 0.027% CN¥ 2.3m | |
| Independent Director | 5.9yrs | CN¥100.00k | no data | |
| Non-Employee Representative Supervisor | 3.1yrs | no data | 0.036% CN¥ 3.0m | |
| Director | 15yrs | CN¥733.80k | 7.5% CN¥ 629.7m | |
| Employee Representative Supervisor | 15yrs | no data | 0.39% CN¥ 32.7m | |
| Chairman of the Board | 15yrs | CN¥1.30m | 11.22% CN¥ 941.3m | |
| Chairman of Supervisor Board | 8.1yrs | no data | 0.20% CN¥ 16.9m | |
| Director | 15yrs | CN¥705.30k | 5.46% CN¥ 458.2m | |
| Independent Director | 2.9yrs | CN¥100.00k | no data | |
| Independent Director | 2.9yrs | CN¥100.00k | no data |
7.7yrs
Average Tenure
55yo
Average Age
Experienced Board: 300463's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Maccura Biotechnology Co.Ltd is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Pei Hui Tang | Chasing Securities |
| Pei Cheng | China Galaxy Securities Co., Ltd. |